Invokana and Korlym drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invokana (canagliflozin) and Korlym (mifepristone). Common drug interactions include localised infection among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Invokana and Korlym. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

On Jul, 15, 2026

88 people who take Invokana and Korlym together, and have interactions are studied.

What are the common drug interactions of Invokana and Korlym, by gender? *:

female:

Localised infection (infection at the single location)
Sinusitis (inflammation of sinus)
Blood creatinine increased
Decreased appetite
Dry mouth
Joint swelling
Muscular weakness (muscle weakness)
Rash erythematous (redness of the skin)
Rash pruritic (redness with itching)
Haemoglobin decreased

male:

Nausea (feeling of having an urge to vomit)
Blood pressure increased
Heart rate decreased
Hypotension (abnormally low blood pressure)
Incisional hernia (hernia caused by an incompletely-healed surgical wound)
Oedema (fluid collection in tissue)
Renal impairment (severely reduced kidney function)
Blood potassium decreased
Peripheral swelling
Blood glucose decreased

What are the common drug interactions of Invokana and Korlym, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Blood testosterone increased
Cold sweat
Disease complication
Fatigue (feeling of tiredness)
Gastric ulcer (stomach ulcer)
Headache (pain in head)
Immune system disorder
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)

40-49:

Blood glucose increased
Fatigue (feeling of tiredness)
Muscular weakness (muscle weakness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight increased

50-59:

Blood pressure increased
Cardiac arrest
Constipation
Decreased appetite
Dry mouth
Fatigue (feeling of tiredness)
Headache (pain in head)
Peripheral swelling
Pleural effusion (water on the lungs)
Pulmonary congestion (congestion in the lungs)

60+:

Nausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)
Blood glucose decreased
Adrenal mass
Heart rate increased
Hot flush (sudden feelings of heat)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Insomnia (sleeplessness)
Tremor (trembling or shaking movements in one or more parts of your body)
Weight decreased

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 84 people, 95.45%

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and Korlym?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously